DNA repair and damage pathways in breast cancer development and therapy
- PMID: 28437752
- DOI: 10.1016/j.dnarep.2017.03.009
DNA repair and damage pathways in breast cancer development and therapy
Abstract
DNA damage/repair constitutes several key pathways working in concert to eliminate DNA lesions and maintain genome stability and integrity. Defective components in DNA damage and repair machinery are an underlying cause for the development and progression of different types of cancers, and breast cancer is no exception. In this paper, we will briefly explain the importance of DNA damage and repair, introduce the current classification schemes for breast cancer, and review the known defects in the repair machinery that have been associated with the risk of breast cancer. Finally, we discuss how the understanding of these pathways can help to design therapeutics for specific targeting of breast cancer tumors.
Keywords: Breast cancer; Chemotherapy; DNA damage; DNA repair.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
DNA damage repair functions and targeted treatment in breast cancer.Breast Cancer. 2020 May;27(3):355-362. doi: 10.1007/s12282-019-01038-2. Epub 2020 Jan 2. Breast Cancer. 2020. PMID: 31898156 Review.
-
DNA damage repair in breast cancer and its therapeutic implications.Pathology. 2017 Feb;49(2):156-165. doi: 10.1016/j.pathol.2016.11.002. Epub 2016 Dec 26. Pathology. 2017. PMID: 28034453 Review.
-
DNA damage response and repair in pancreatic cancer development and therapy.DNA Repair (Amst). 2021 Jul;103:103116. doi: 10.1016/j.dnarep.2021.103116. Epub 2021 Apr 15. DNA Repair (Amst). 2021. PMID: 33882393 Review.
-
Targeting DNA repair in breast cancer: a clinical and translational update.Cancer Treat Rev. 2010 Nov;36(7):557-65. doi: 10.1016/j.ctrv.2010.03.006. Epub 2010 Apr 10. Cancer Treat Rev. 2010. PMID: 20385443 Review.
-
Defective DNA repair systems and the development of breast and prostate cancer (review).Int J Oncol. 2013 Jan;42(1):29-34. doi: 10.3892/ijo.2012.1696. Epub 2012 Nov 14. Int J Oncol. 2013. PMID: 23151935 Review.
Cited by
-
Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer.Front Oncol. 2023 Jan 11;12:1085632. doi: 10.3389/fonc.2022.1085632. eCollection 2022. Front Oncol. 2023. PMID: 36713553 Free PMC article.
-
Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor.Genes (Basel). 2022 Jul 6;13(7):1208. doi: 10.3390/genes13071208. Genes (Basel). 2022. PMID: 35885991 Free PMC article.
-
Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer.Braz J Med Biol Res. 2022 Mar 11;55:e11857. doi: 10.1590/1414-431X2021e11857. eCollection 2022. Braz J Med Biol Res. 2022. PMID: 35293552 Free PMC article.
-
SUN2: A potential therapeutic target in cancer.Oncol Lett. 2019 Feb;17(2):1401-1408. doi: 10.3892/ol.2018.9764. Epub 2018 Nov 27. Oncol Lett. 2019. PMID: 30675193 Free PMC article. Review.
-
ATPase copper transporter A, negatively regulated by miR-148a-3p, contributes to cisplatin resistance in breast cancer cells.Clin Transl Med. 2020 Jan;10(1):57-73. doi: 10.1002/ctm2.19. Epub 2020 Apr 7. Clin Transl Med. 2020. PMID: 32508020 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical